Bard Associates Inc Nephros Inc Transaction History

Bard Associates Inc

$327 Million
Q3 2025

A detailed history of Bard Associates Inc transactions in Nephros Inc stock. As of the latest transaction made, Bard Associates Inc holds 127,121 shares of NEPH stock, worth $559,332. This represents 0.18% of its overall portfolio holdings.

Number of Shares

127,121

Previous 131,121 3.05%

Holding current value

$559,332

Previous $536,000 12.13%

% of portfolio

0.18%

Previous 0.2%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$2.97 - $4.73 $11,880 - $18,920	-4,000 Reduced 3.05%	127,121 $601,000
Q2 2025 Aug 05, 2025	SELL	$1.8 - $5.0 $21,780 - $60,500	-12,100 Reduced 8.45%	131,121 $536,000
Q1 2025 May 09, 2025	SELL	$1.41 - $1.72 $16,990 - $20,726	-12,050 Reduced 7.76%	143,221 $246,000
Q4 2024 Feb 06, 2025	SELL	$1.36 - $1.69 $23,256 - $28,899	-17,100 Reduced 9.92%	155,271 $229,000
Q3 2024 Nov 06, 2024	SELL	$1.71 - $2.29 $5,514 - $7,385	-3,225 Reduced 1.84%	172,371 $294,000

Q2 2024 Aug 12, 2024	SELL	$1.99 - $2.36 $7,522 - $8,920	-3,780 Reduced 2.11%	175,596 $370,000
Q1 2024 May 13, 2024	SELL	$2.11 - $3.78 $16,757 - $30,020	-7,942 Reduced 4.24%	179,376 $392,000
Q4 2023 Feb 13, 2024	BUY	$1.46 - $3.91 $1,867 - $5,000	1,279 Added 0.69%	187,318 $648,000
Q3 2023 Nov 13, 2023	SELL	$1.35 - $1.72 $9,315 - $11,868	-6,900 Reduced 3.58%	186,039 $275,000
Q2 2023 Aug 11, 2023	SELL	$1.14 - $2.02 $1,538 - $2,727	-1,350 Reduced 0.69%	192,939 $299,000
Q1 2023 May 12, 2023	SELL	$0.97 - $1.35 $485 - $675	-500 Reduced 0.26%	194,289 $207,000
Q4 2022 Feb 10, 2023	SELL	$0.93 - $1.25 $53,321 - $71,668	-57,335 Reduced 22.74%	194,789 $225,000
Q3 2022 Nov 09, 2022	SELL	$0.91 - $1.87 $10,583 - $21,748	-11,630 Reduced 4.41%	252,124 $229,000
Q2 2022 Aug 11, 2022	BUY	$1.47 - $4.63 $25,498 - $80,311	17,346 Added 7.04%	263,754 $404,000
Q1 2022 May 11, 2022	BUY	$3.89 - $6.12 $54,071 - $85,068	13,900 Added 5.98%	246,408 $1.08 Million
Q4 2021 Feb 14, 2022	SELL	$5.87 - $8.46 $9,979 - $14,382	-1,700 Reduced 0.73%	232,508 $1.37 Million
Q3 2021 Nov 12, 2021	BUY	$7.6 - $10.01 $20,520 - $27,027	2,700 Added 1.17%	234,208 $2.05 Million
Q2 2021 Aug 12, 2021	BUY	$6.61 - $10.68 $80,179 - $129,548	12,130 Added 5.53%	231,508 $2.35 Million
Q1 2021 May 13, 2021	BUY	$6.65 - $8.93 $83,324 - $111,892	12,530 Added 6.06%	219,378 $1.46 Million
Q4 2020 Feb 11, 2021	BUY	$5.86 - $8.58 $29,593 - $43,329	5,050 Added 2.5%	206,848 $1.78 Million
Q3 2020 Nov 12, 2020	SELL	$5.58 - $8.45 $3,744 - $5,669	-671 Reduced 0.33%	201,798 $1.46 Million
Q2 2020 Aug 13, 2020	SELL	$6.15 - $9.35 $31,365 - $47,685	-5,100 Reduced 2.46%	202,469 $1.7 Million
Q1 2020 May 13, 2020	BUY	$5.99 - $10.29 $1.24 Million - $2.14 Million	207,569 New	207,569 $2.64 Million

Others Institutions Holding NEPH

# of Institutions

Shares Held

4.42M

Call Options Held

Put Options Held

View Full List

About NEPHROS INC

Ticker NEPH
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 10,318,800
Market Cap $45.4M
Description
Nephros, Inc. develops and sells high performance water solutions to the medical and commercial markets in the United States. The company operates in three segments: Water Filtration, Pathogen Detection, and Renal Products. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water ...

More about NEPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bard Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bard Associates Inc with notifications on news.

Account

Bard Associates Inc Nephros Inc Transaction History